A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of Orismilast in Adults with Moderate-to-Severe Plaque-Type Psoriasis

To evaluate the efficacy and safety of a modified-release Orismilast tablets in adults with moderate-to-severe plaque-type psoriasis.

Principal Investigator(s)

Dr. Jonathan Silverberg MD, PHD, MPH

Contact Phone Number

Request Information

First Name

Last Name

Email Address

Confirm email

Phone Number

Address

Address 2

City/Town

State/Province

ZIP/Postal Code

Comments / Questions

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.